SJR72 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Securities and Exchange Commission relating to "The Enhancement and Standardization of Climate-Related Disclosures for Investors".

39 Co-Sponsors

SR559 - A resolution recognizing the actions of the Rapid Support Forces and allied militia in the Darfur region of Sudan against non-Arab ethnic communities as acts of genocide.

7 Co-Sponsors

SB3473 - Air Security Act of 2023

2 Co-Sponsors

A bill to extend the prohibition on providing airport improvement grant funds to certain entities that have violated intellectual property rights of United States entities.

SB1473 - A bill to authorize the immediate expulsion of inadmissible aliens attempting to enter the United States by fraud or without a necessary entry document, and for other purposes.

8 Co-Sponsors

SB4253 - A bill to ensure that United States diplomats and officials of the U.S. Section of the International Boundary and Water Commission are able to advance efforts seeking compliance by the United Mexican States with the 1944 Treaty on Utilization of Waters of the Colorado and Tijuana Rivers and of the Rio Grande.

2 Co-Sponsors

SJR74 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Greenhouse Gas Emissions Standards for Heavy-Duty Vehicles-Phase 3".

45 Co-Sponsors

SR669 - A resolution designating October 10, 2024, as "American Girls in Sports Day".

40 Co-Sponsors

SR673 - A resolution honoring the life of David Hampton Pryor, former United States Senator for the State of Arkansas.

100 Co-Sponsors

SR668 - A resolution honoring the life of Daniel Robert "Bob" Graham, former Senator for the State of Florida.

100 Co-Sponsors

SB4229 - Reducing Drug Prices for Seniors Act.

2 Co-Sponsors

A bill to amend title XVIII of the Social Security Act to require that coinsurance for drugs under Medicare part D be based on the drug's net price and not the drug's list price.